News Bliss GVS Pharma Limited NSE India S.E.

Equities

BLISSGVS

INE416D01022

Market Closed - NSE India S.E. Other stock markets 07:40:29 2024-07-16 am EDT			5-day change	1st Jan Change
114.1 ^INR	-1.66%		+2.35%	-8.49%

Jun. 21	Office of the Joint Commissioner, Food and Drugs Administration Orders for Suspension of FDA License Issued to Tablet Division of Manufacturing Unit	CI
Jun. 20	Crisil Keeps BBB+ Rating on Bliss GVS Pharma's Bank Loans; Outlook Stable	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Office of the Joint Commissioner, Food and Drugs Administration Orders for Suspension of FDA License Issued to Tablet Division of Manufacturing Unit	Jun. 21	CI
Crisil Keeps BBB+ Rating on Bliss GVS Pharma's Bank Loans; Outlook Stable	Jun. 20	MT
Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 02	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 02	CI
Bliss Gvs Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024, Payable on or Before August 24, 2024	May. 02	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 23	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 01	CI
Assistant Commission of State Tax Maharashtra, Mumbai Initiates Search At Certain Premises of Bliss GVS Pharma Limited	23-09-07	CI
Bliss Gvs Pharma Limited Announces Change in the Designation of Mr. Vishal Vijay Rao	23-08-01	CI
Bliss GVS Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-01	CI
Bliss GVS Pharma Limited Declares Final Dividend for the Financial Year Ended March 31, 2023	23-07-19	CI
Ex-dividend day for final dividend	23-07-11	FA
Bliss GVS Pharma Gets Establishment Inspection Report from US FDA for Palghar, India Unit	23-06-15	MT
Bliss Gvs Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	23-05-11	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-11	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-11	CI
Infomerics Keeps BBB Rating on Bliss GVS Pharma's Bank Financing; Outlook Stable	23-04-10	MT
Bliss GVS Pharma Gets Three Observations from US FDA's Plant Inspection in Maharashtra, India	23-03-20	MT
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-24	CI
Bliss GVS Pharma Names New CFO	22-12-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bliss GVS Pharma Limited NSE India S.E.

Equities

BLISSGVS

INE416D01022

Summary

Filters